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1072Objective: This was a single-center retrospective study to assess the surgical outcomes and predictors of
mortality of liver transplant recipients undergoing cardiac surgery.
Methods: From 2000 to 2010, 61 patients with a functioning liver allograft underwent cardiac surgery. Themean
interval between liver transplantation and cardiac surgery was 5.4 4.4 years. Of the 61 patients, 33 (54%) were
in Child-Pugh class A and 28 in class B. The preoperative and postoperative data were reviewed.
Results: The overall in-hospital mortality was 6.6%. The survival rate was 82.4%  5.1% at 1 year and
50.2%  8.2% at 5 years. Cox regression analysis identified preoperative encephalopathy (odds ratio, 5.2;
95% confidence interval, 1.8-15.5; P¼ .003) and pulmonary hypertension (odds ratio, 3.5; 95% confidence in-
terval, 1.3-9.4; P ¼ .045) as independent predictors of late mortality. The preoperative Model for End-Stage
Liver Disease (MELD) scores of patients who died in-hospital or late postoperatively were significantly greater
statistically than the scores of the others (in-hospital death, 23.7  7.8 vs 13.1  4.5, P< .001; late death,
15.2  6.1 vs 12.3  4.1, P ¼ .038). The Youden index identified an optimal MELD score cutoff value of
13.5 (sensitivity, 56.0%; specificity, 67.6%). Kaplan-Meier survival analysis successfully demonstrated that
the survival rate of the MELD score less than 13.5 (MELD<13.5) group was significantly greater than that
of the MELD>13.5 group (MELD<13.5 group, 93.8%  4.2% at 1 year and 52.4%  11.8% at 5 years;
MELD>13.5 group, 66.9% 9.6% at 1 year and 46.1% 11.1% at 5 years;P¼ .027). In contrast, the survival
rate when stratified by Child-Pugh class (class A vs B) was not significantly different.
Conclusions: Cardiac surgery in the liver allograft recipients was associated with acceptable surgical outcomes.
Preoperative encephalopathy and pulmonary hypertension were independent predictors of late mortality. The
cutoff value of 13.5 in the MELD score might be useful for predicting surgical mortality in cardiac surgery.
(J Thorac Cardiovasc Surg 2013;145:1072-6)The survival of liver transplant recipients has been im-
proved by the remarkable advances in surgical technique,
pre- and postoperative management, and immunosuppres-
sive protocols,1 resulting in a potential increase in the num-
ber of patients with a history of liver transplantation
requiring cardiac surgery. It has been reported that more
than 70% of liver allograft recipients experience cardiac
events,2 that cardiac complications after liver transplanta-
tion are common, and that these have been the leading cause
of death after liver transplantation.3 Organ allograft recipi-
ents require immunosuppressant agents, placing the pa-
tients at great risk of peri- and postoperative infection.4 It
has also been assumed that the liver functional reserve in
liver transplantation recipients is subnormal,5 leading toe Division of Cardiac Surgery, Department of Cardiothoracic Surgery,
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The Journal of Thoracic and Cardiovascular Suran increased risk of surgical morbidity and mortality. Al-
though this topic is an important entity in clinical practice,
only a few of studies are available.
The purpose of the present study was to summarize our
experience with surgical management of patients with a his-
tory of liver transplantation who were undergoing cardiac
surgery and to determine the short- and long-term surgical
outcomes and predictors of mortality.PATIENTS AND METHODS
The quality improvement review committee of the University of Pitts-
burgh Medical Center approved the present study and waived the need
for patient consent. From January 2000 to June 2010, 61 patients with
a functioning liver allograft who were undergoing cardiac surgery at the
University of Pittsburgh Medical Center were identified, and their data
were retrospectively collected from our cardiac surgical database and a re-
view of their medical records. The mean follow-up period was 3.1  2.6
years. The follow-up was completed by telephone interview, and late out-
comes were cross-referenced using the Social Security Death Index. The
patient demographics are detailed in Table 1. Their mean age was
61.5  8.2 years. Of the 61 patients, 45 (73.8%) were men; 19 patients
(31.1%) had chronic renal insufficiency preoperatively, defined as a base-
line serum creatinine>2.0 mg/dL, and 13 patients (21.3%) required dial-
ysis. The Child-Pugh class was class A for 33 patients (54%) and class B
for 28 patients (46%). No patient in Child-Pugh class C underwent cardiac
surgery. All patients were treated and followed up by our liver transplanta-
tion team for pre- and postoperative management. Pre- and postoperativegery c April 2013
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patic encephalopathy grading system.6 The mean preoperative Model for
End-Stage Liver Disease (MELD) score was 13.5 5.2. The mean interval
between liver transplantation and cardiac surgery was 5.4 4.4 years. The
primary surgical indications included coronary artery disease in 31, valvu-
lar disease in 25 (aortic valve in 17, mitral valve in 4, aortic and mitral
valves in 3, and tricuspid valve in 1), and other indications in 5. Of the
61 patients, 11 (18%) required emergent surgery. The indications for
emergent surgery were unstable acute coronary syndrome in 6, acute endo-
carditis with acute heart failure in 3, and critical aortic stenosis with
progressively deteriorating hemodynamics in 2. Six patients (9.8%) has
acute endocarditis diagnosed according to the Duke criteria.7
Statistical Analysis
Continuous variables are reported as the mean standard deviation and
categorical variables as frequencies. Fisher’s exact test or the chi-square
test was used to evaluate categorical variables on univariate analysis. Stu-
dent’s t test or the Mann-Whitney U test was used for the continuous vari-
ables owing to the distribution of the data. The Kaplan-Meier model was
used to calculate the estimates for long-term survival. The logistic regres-
sion model and Cox regression model was used to determine the indepen-
dent predictors of in-hospital mortality and late mortality, respectively.
Only variables with P<.05 on univariate analysis were retained for the
multivariate regression tests. For all analyses, 2-sided tests were used.
The sensitivity and specificity of the preoperative MELD score as an indi-
cator of mortality were determined from the cutoff values. Receiver oper-
ating characteristic (ROC) curves and the area under the curve (AUC) for
the ROC curve were obtained by plotting the sensitivity against the false-
positive rate (1  specificity). The Youden index was used to determine
the optimal cutoff values of the MELD score for identification of the sur-
gical risk of mortality (Youden index ¼ sensitivity þ specificity  1).
All statistical analyses were performed using SPSS (SPSS, Chicago, Ill).T
XRESULTS
The surgical procedures are summarized in Table 2. Iso-
lated coronary artery bypass grafting was performed in 31
patients. The off-pump technique was used in 13 (42%)
of the isolated coronary artery bypass grafting 31 cases. Sin-
gle valve replacement or repair was required in 13 cases
(21.3%; aortic valve in 9, mitral valve in 3, and tricuspid
valve in 1). Double valve surgery (aortic and mitral valves)
was performed in 3. Concomitant coronary artery bypass
grafting was performed in 8 patients, along with single
valve surgery (aortic valve in 6, mitral valve in 1, and aortic
root replacement in 1).
The operative data and postoperative complications are
listed in Table 3. The mean cardiopulmonary bypass time
was 130 64 minutes. Four patients (6.6%) required reop-
eration for bleeding. Eleven patients (18.0%) experienced
prolonged intubation, defined as intubation for longer than
72 hours, and 5 of these patients subsequently requiredThe Journal of Thoracic and Cartracheostomy. Sevenpatients (11.5%) developed acute renal
failure, defined as newly occurring postoperative peak serum
creatinine>2.0mg/dL. Four patients (6.6%) newly required
dialysis in the postoperative period. Postoperative infection
(ie, bacteremia, pneumonia) occurred in 15 patients
(24.6%). Postoperative liver complications during the
follow-up period developed in 19 patients: 7 developed asci-
tes (5 in the postoperative in-hospital period and 2 after dis-
charge) and 12 developed encephalopathy (8 in the
postoperative in-hospital period and 4 after discharge). Ad-
ditional liver complications occurring after discharge in-
cluded drug-induced liver dysfunction in 1, bile stricture in
2, graft rejection in 2, and recurrent hepatitis C in 1 patient.
The graft rejection was likely because of noncompliance
with the immunosuppressant therapy in 1 patient. The sec-
ond patient required subsequent liver repeat transplantation
about 5 months after cardiac surgery for unknown reasons.
The overall in-hospital mortality was 6.6% (4/61). The
in-hospital mortality stratified by Child-Pugh class was
6.1% (2/33) and 7.1% (2/28) for class A and B, respec-
tively (P ¼ 1.00), Univariate analysis identified preopera-
tive dialysis (P ¼ .008), serum creatinine >2.0 mg/dL
(P ¼ .027), and active endocarditis (P ¼ .023) as preopera-
tive predictors and reoperation for bleeding (P ¼ .01), pro-
longed intubation (P ¼ .005), new requirement for dialysis
(P ¼ .016), and new-onset encephalopathy (P ¼ .043) as
postoperative predictors of in-hospital mortality. No predic-
tor of in-hospital mortality, however, was identified on mul-
tivariate analysis. Emergent surgery was not a predictor of
in-hospital or late mortality (P ¼ .14 and P ¼ .50, respec-
tively). The preoperative MELD score was significantly
greater for the patients who died in-hospital than for those
who survived to discharge (23.7  7.8 vs 13.1  4.5;
P<.001). The survival rate was 82.4%  5.1% at 1 year,
71.8%  6.3% at 3 years, and 50.2%  8.2% at 5 years
after cardiac surgery. Comparing Child-Pugh class A and
B, the survival rates were 83.5%  6.8% at 1 year and
57.2%  10.3% at 5 years for Child-Pugh class A and
81.1%  7.6% at 1 year and 39.7%  13.2% at 5 years
for Child-Pugh class B, respectively, with no significant dif-
ference (log-rank test, P¼ .603; Figure 1, A). On univariate
analysis, the statistically significant factors associated with
late mortality were preoperative encephalopathy
(P ¼ .012), serum creatinine>2.0 mg/dL (P ¼ .012), and
pulmonary hypertension, defined as pulmonary systolic
pressure>60 mm Hg (P ¼ .016). The Cox regression anal-
ysis revealed preoperative encephalopathy (odds ratio, 5.2;
95% confidence interval 1.8-15.5; P ¼ .003) and preopera-
tive pulmonary hypertension (odds ratio, 3.5; 95% confi-
dence interval, 1.3-9.4; P ¼ .045) as independent
predictors of late mortality. The preoperative MELD score
for the late mortality group was significantly greater statis-
tically than in the survivors (15.2  6.1 vs 12.3  4.1;
P ¼ .038). The Youden index revealed that the optimaldiovascular Surgery c Volume 145, Number 4 1073
TABLE 1. Patient preoperative demographics (n ¼ 61)
Characteristic Value
Age (y) 61.5  8.2
Gender
Male 45
Female 16
Diabetes mellitus 46 (75.4%)
Smoker 12 (19.7%)
Hypertension 42 (68.9%)
Hyperlipidemia 18 (29.5%)
Cerebrovascular accident 8 (13.1%)
Chronic renal insufficiency (serum creatinine>2.0 mg/dL) 19 (31.1%)
Dialysis 13 (21.3%)
Peripheral vascular disease 27 (44.3%)
COPD 10 (16.4%)
Child-Pugh classification
A 33 (54.1%)
B 28 (45.9%)
C 0 (0%)
MELD score 13.5  5.2
Ascites 10 (16.4%)
Encephalopathy 5 (8.2%)
LVEF<35% 7 (11.5%)
Pulmonary hypertension 8 (13.1%)
Recent myocardial infarction (<90 d) 14 (23.0%)
Surgical indication
Coronary artery disease 31 (50.8%)
Valvular disease 25 (41.0%)
Other 5 (8.2%)
Acute endocarditis 6 (9.8%)
Emergent operation 11 (18.0%)
Previous cardiac surgery 5 (8.2%)
Interval between liver transplantation and cardiac surgery (y) 5.4  4.4
Data presented as mean  standard deviation or n (%). COPD, Chronic obstructive
pulmonary disease; MELD,Model for End-Stage Liver Disease; LVEF, left ventricu-
lar ejection fraction.
TABLE 3. Operative data, postoperative complications, and early and
late mortality (n ¼ 61)
Variable Value
CPB time (min) 130  64
Required IABP 4 (6.6%)
Take-back for bleeding 4 (6.6%)
Prolonged intubation (>72 h) 11 (18.0%)
Reintubation 9 (14.8%)
Tracheostomy 5 (8.2%)
Pneumonia 9 (14.8%)
Bacteremia 6 (9.8%)
Atrial fibrillation 21 (34.4%)
Acute renal failure (peak creatinine>2.0 mg/dL) 7 (11.5%)
Newly required dialysis 4 (6.6%)
Myocardial infarction 1 (1.6%)
Cerebrovascular accident 4 (6.6%)
New-onset ascites 7 (11.8%)
In-hospital 5 (8.2%)
After discharge 2 (3.3%)
New-onset encephalopathy 12 (19.6%)
In-hospital 8 (13.1%)
After discharge 4 (6.6%)
Liver complications 6 (9.8%)
Peak total bilirubin>3.0 mg/dL 6 (9.8%)
In-hospital mortality 4 (6.6%)
Child-Pugh class A 2/33 (6.1%)
Child-Pugh class B 2/28 (7.1%)
All deaths 26 (42.6%)
Child-Pugh class A 14/33 (42.4%)
Child-Pugh class B 12/28 (42.9%)
Primary cause of death (n ¼ 26)
Cerebrovascular accident 4 (6.6%)
Cardiac 3 (4.9%)
Respiratory 5 (8.2%)
Cancer 2 (3.3%)
Infection 1 (1.6%)
Unknown 11 (18.0%)
CPB, Cardiopulmonary bypass; IABP, intra-aortic balloon pump.
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X cutoff for the preoperative MELD score was 13.5 for pre-
dicting overall postoperative mortality. The ROC curve in-
dicated that the sensitivity and specificity was 0.56 andTABLE 2. Surgical procedures (n ¼ 61)
Procedure Value
Isolated CABG 31 (50.8%)
Off-pump 13/31
On-pump 18/31
AVR 9 (14.8%)
MV replacement or repair 3 (4.9%)
TV repair 1 (1.6%)
AVR plus MV replacement/repair 3 (4.9%)
CABG plus AVR 6 (9.8%)
CABG plus MV replacement 1 (1.6%)
CABG plus aortic root replacement 1 (1.6%)
Aortic root replacement 1 (1.6%)
Other 5 (8.2%)
Data presented as n (%). CABG, Coronary artery bypass grafting; AVR, aortic valve
replacement; MV, mitral valve; TV, tricuspid valve.
1074 The Journal of Thoracic and Cardiovascular Sur0.68, respectively, for the optimal cutoff of 13.5. The
AUC of the ROC curve was 0.633 (95% confidence inter-
val, 0.484-0.782). In the present cohort, 35 patients had
a preoperative MELD score less than 13.5 and 26 patients
a score greater than 13.5. The Kaplan-Meier survival anal-
ysis revealed that the survival rate for the MELD score
<13.5 group was significantly greater than that for the
MELD score>13.5 group (93.8%  4.2% at 1 year and
52.4%  11.8% at 5 years for the MELD score<13.5
group and 66.9%  9.6% at 1 year and 46.1%  11.1%
at 5 years for the MELD score>13.5 group; log-rank test,
P ¼ .027; Figure 1, B).DISCUSSION
Liver transplantation is an established strategy to treat
end-stage liver disease. It has been reported that the survival
rate of liver transplant recipients is 84% at 1 year and 67%gery c April 2013
FIGURE 1. A, Kaplan-Meier survival curves. Child-Pugh class A group versus Child-Pugh class B group (solid line, Child-Pugh class A; dashed line,
Child-Pugh class B; log-rank, P ¼ .60). B, Kaplan-Meier survival curves for Model for End-Stage Liver Disease (MELD) score<13.5 group versus
MELD score>13.5 group (solid line, MELD score<13.5; dashed line, MELD score>13.5; log-rank, P ¼ .027).
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Xat 5 years.8 Recent immunosuppressive regimens have
included a combination of a calcineurin inhibitor and corti-
costeroids/mycophenolate mofetil/sirolimus. Although the
current immunosuppressive regimens have played an im-
portant role in improving the outcomes of transplantation,
these medications are associated with exacerbation of sys-
temic and metabolic disorders, including, but not limited
to, hypertension, diabetes mellitus, hyperlipidemia, and
obesity.9 Johnston and colleagues10 reported that liver allo-
graft recipients have a greater risk of cardiovascular death
and ischemic events than an age- and gender-matched pop-
ulation. With the increased life expectancy and increased
risks of cardiovascular diseases for liver allograft recipients,
it would be reasonable to assume that the number of liver
recipients in need of cardiac surgery could be increasing.
Cardiac surgery for patients with liver dysfunction is still
challenging. It has generally been accepted that patients in
Child-Pugh class C are contraindicated for cardiac sur-
gery.11 Our institution has been following that surgical indi-
cation; subsequently, only patients with Child-Pugh class A
or B were involved in the present study. Cardiac surgery for
patients with cirrhosis has been well documented. Report-
edly, the operative mortality of patients with Child-Pugh
class A, B, and C has ranged from 3% to 5%, 35% to
50%, and 70% to 100%, respectively.12-14 In the present
study, the overall survival rate was 82.4%  5.1% at 1
year and 50.2%  8.2% at 5 years, comparable to that of
other investigator.15 During the follow-up period, only 1 pa-
tient (1.6%) lost the liver allograft and required subsequent
liver repeat transplantation. We believe that the early and
late outcomes in the present study were acceptable.
Realizing that patients with cirrhosis and those with
a functioning liver allograft represent different populations,The Journal of Thoracic and Carthe present study has showed that the overall in-hospital
mortality was 6.6% and for Child-Pugh class A and B
was 6.1% and 7.1%, respectively, with no statistically sig-
nificant difference. In addition, the Kaplan-Meier survival
analysis showed no significant difference in the survival
rates between the Child-Pugh class A and B groups
(Child-Pugh class A, 83.5%  6.8% at 1 year and
57.2%  10.3% at 5 years vs Child-Pugh class B,
81.1%  7.6% at 1 year and 39.7%  13.2% at 5 years;
log-rank, P ¼ .603). This discrepancy between patients
with cirrhosis and patients with a functioning liver allograft
might be a limitation of the Child-Pugh classification sys-
tem, which uses arbitrary cutoff values.
However, the MELD score system makes an incremental
contribution to the score for each 1-point increase in the fac-
tors. Therefore, it can be expected that the MELD score will
increase the precision in predicting postoperative mortality.
The MELD score (range, 6 to 40), which is a linear regres-
sion model calculated from the serum bilirubin, interna-
tional normalized ratio of prothrombin time, and serum
creatinine, was adopted in liver transplantation for alloca-
tion purposes.16 The MELD score is a well-known good
predictor of waiting list mortality and post-liver transplant
mortality and has recently been used to predict periopera-
tive mortality in the different categories of surgery. It has
been reported that the MELD score is the most precise sin-
gle predictor of perioperative mortality.11 However, it has
not been well documented in the field of cardiac surgery.
In the present study, we sought to establish a cutoff value
for the MELD score to predict the mortality of cardiac sur-
gery for patients with a functioning liver allograft. The pres-
ent study showed that the mean of the preoperative MELD
score for the patients who died postoperatively wasdiovascular Surgery c Volume 145, Number 4 1075
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Xsignificantly greater than that of the other patients. From the
statistical analysis, the optimal cutoff value was identified
as 13.5. This cutoff value is similar to those previously re-
ported to predict the surgical mortality of patients with cir-
rhosis (eg, MELD score>13).14 To reconfirm the adequacy
of the cutoff value (ie, 13.5), an additional Kaplan-Meier
analysis was performed by regrouping the cohort into 2
groups (ie, patients with a MELD score of >13.5
or<13.5). This analysis successfully showed that the sur-
vival rate of the group with a MELD score less than 13.5
was significantly greater than that of those with a MELD
score greater than 13.5 (log-rank, P ¼ .027).
The study limitations included the retrospective nature
and analysis and the relatively small number of patients.
However, the present study is 1 of the largest series of car-
diac surgery in liver transplant recipients. In addition, we
acknowledge that the sensitivity and specificity of the cutoff
value of 13.5 of the MELD score was only 56% and 68%,
respectively. The AUCwas 0.633, considered of ‘‘low accu-
racy.’’ It is generally accepted that an AUC of 0.9 to 1.0 rep-
resents high accuracy, an AUC of 0.7 to 0.9 as moderate
accuracy, and AUC of 0.5 to 0.7 as low accuracy.17 How-
ever, the cutoff value of 13.5 was shown to predict late mor-
tality in the present study with statistical significance.
Therefore, we believe that the preoperative MELD score
should be 1 of the important parameters to evaluate when
assessing patients with liver issues for surgery. Regarding
the postoperative liver complications, although the new on-
set of ascites and encephalopathy during the postoperative
in-hospital period was likely related to the cardiac surgery,
it is unclear whether the other liver complications that oc-
curred in the chronic phase resulted from cardiac surgery
or simply reflected the natural history of the liver transplant
recipients. Also, although postoperative encephalopathy
was diagnosed by the liver transplantation team, we
acknowledge that it is sometimes difficult and confusing
to differentiate hepatic encephalopathy from common post-
operative delirium.
CONCLUSIONS
We reviewed our experience with the surgical treatment
and outcomes of cardiac surgery for patients with a func-
tioning liver allograft. The surgical outcomes in the pres-
ent study were acceptable in terms of both the in-hospital1076 The Journal of Thoracic and Cardiovascular Surand the late outcomes. Preoperative encephalopathy and
pulmonary hypertension were independent predictors of
late mortality. The optimal cutoff value of the preopera-
tive MELD score was identified as 13.5 for predicting
surgical mortality. The preoperative MELD score could
possibly be useful to predict surgical mortality for patients
with liver dysfunction who are undergoing cardiac
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